Archive

ShareThis Page
Fox Chapel man’s death linked to anti-diarrheal overdose | TribLIVE.com
Allegheny

Fox Chapel man’s death linked to anti-diarrheal overdose

ptrimodium1020118
Imodium
Imodium
6532996PatelArjun29
Arjun Patel

A Fox Chapel man found dead in his home in November died from an overdose of an anti-diarrhea medication that can be used to mimic the high of opioids, medical examiner records show.

Arjun Patel, 29, was pronounced dead Nov. 8. A notice from the Allegheny County Medical Examiner earlier this week lists Patel’s cause of death as loperamide poisoning.

Loperamide, a drug with opioid-like side effects, is found in Imodium AD — a medication used to treat short-term bouts of diarrhea. High doses of the drug can create feelings of exhilaration akin to those brought on by other opioids.

Dr. Mike Lynch, an emergency room doctor and toxicologist with the Pittsburgh Poison Center at UPMC, said he has seen a significant increase in toxic doses of loperamide — between 2015 and 2017, the center saw a 167-percent increase in calls relating to the drug.

In January, the Food and Drug Administration announced plans to place restrictions on Imodium packaging , recommending that it be “limited to eight 2-milligram capsules in blister packaging.”

The call for packaging limitations came months after Patel’s death.

Loperamide is sometimes referred to as “poor man’s methadone,” according to the Washington Post.

“When used at extremely high and dangerous doses, it’s seen by those suffering from opioid addiction as a potential alternative to manage opioid withdrawal symptoms or to achieve the euphoric effects of opioid use,” FDA Commissioner Scott Gottlieb said in a statement.

Megan Guza is a Tribune-Review staff writer.

TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.